Becker News and Research

RSS

Study links a novel protein pathway to the aggressive progression of breast cancer

Cytogen Corporation today announced the publication of a study linking a novel protein pathway to the aggressive progression of breast cancer.

24 Nov 2004

Reproductive hormones have effects on all of these stages of brain growth and development

Scientists are now uncovering increasing evidence that the brain not only responds to hormones produced by the reproductive system, but that these hormones-the so-called "female hormones," estrogen and progestin, and the "male" androgens, such as testosterone-play an important role in the development of differences between male and female brains.

2 Nov 2004

Researchers have uncovered a specific signaling mechanism that contributes to the development of colorectal cancer

The discovery furthers the understanding of mechanisms that contribute to disease progression and provides new avenues for development of therapies for colorectal cancer.

21 Oct 2004

Researchers help neonatal specialists administer a replacement substance that helps babies breathe easier

When babies are born prematurely, their lungs are not able to produce a protein that helps them breathe.

13 Oct 2004

Data suggests potential role of Quadramet in conjunction with chemotherapy for the treatment of acute myeloid leukemia

Cytogen Corporation today announced the presentation of new data relating to its lead therapeutic product Quadramet (samarium Sm-153 lexidronam injection) during the 36th Congress of the International Society of Pediatric Oncology (SIOP).

20 Sep 2004

German researchers are identifying lymphoma risks

Little is known about the causes of lymphoma. A case-control study conducted by Professor Nikolaus Becker and Dr. Alexandra Nieters, Division of Clinical Epidemiology at the Deutsches Krebsforschungszentrum (German Cancer Research Center, DKFZ), is looking closely at possible risk factors.

14 Sep 2004

Full-term infants born to nonsmoking women living within two miles of the WTC weighed significantly less

A new study examines the effect of exposure to the September 11, 2001 destruction of the World Trade Center (WTC) on nonsmoking women who were pregnant at that time and delivered at three hospitals in lower Manhattan.

10 Sep 2004

Pfizer files lawsuits against eighteen internet sites for selling illegal copies of LIPITOR

Pfizer has filed lawsuits against a second group of operators of eighteen internet sites for selling unapproved and illegal copies of Pfizer’s leading cholesterol medicine, LIPITOR®, the company said today.

2 Sep 2004

Tobacco industry's efforts to influence the print media

A study based on the tobacco industry's own documents shows the extent of the tobacco industry's efforts to influence the print media on the health effects of secondhand smoke.

7 Aug 2004

Proof of principle that it is possible to deliver new genes body-wide to all the muscles of an adult animal

MDA-supported researchers at the University of Washington-Seattle have delivered the gene for the dystrophin protein to all voluntary muscles with a single intravenous injection in mice with Duchenne muscular dystrophy (DMD).

29 Jul 2004

Chemicals that inhibit the development of new blood vessels could prove to be a new way of treating endometriosis

Chemicals that inhibit the development of new blood vessels could prove to be a new way of treating endometriosis, according to research from The Netherlands and the USA presented today (Monday 28 June) at the 20th annual meeting of the European Society of Human Reproduction and Embryology.

28 Jun 2004

MDA researchers find creatine helps in Duchenne dystrophy

Grip strength in the dominant hand and fat-free body mass (made mostly of muscle) increased when children with Duchenne muscular dystrophy (DMD) took the dietary supplement creatine at a dose of 0.1 grams per kilogram of body weight per day for four months.

25 May 2004

Anti-clotting treatment underused at many hospitals

Academic hospitals are more likely than community or Veteran’s Administration (VA) hospitals to follow national guidelines for treating patients at risk for blood clots with aspirin or warfarin.

19 May 2004